Hua Ren
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hua Ren has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Changjiu He
Affiliation The Clinical Hospital of Chengdu Brain Science Institute, MOE Key Lab for Neuroinformation, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, P.R. China
2 shared publicationsJian Jiao
Affiliation Sleep Medicine Center, Mental Health Center, Translational Neuroscience Center, West China Hospital, Sichuan University, Chengdu, P.R. China
2 shared publicationsQin Yang
Affiliation The Clinical Hospital of Chengdu Brain Science Institute, MOE Key Lab for Neuroinformation, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, P.R. China
2 shared publications- Zaiquan Dong
Mental Health Center, West China Hospital, Sichuan University, Chengdu 610041, PR China
2 shared publications Ao Xie
School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, China
1 shared publicationDezhong Yao
The Clinical Hospital of Chengdu Brain Science Institute, MOE Key Lab for Neuroinformation, University of Electronic Science and Technology of China, Chengdu, China; School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, China; Research Unit of NeuroInformation, Chinese Academy of Medical Sciences, 2019RU035, Chengdu, China
1 shared publication
Latest Publications
- Open Access
- 9 January 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (1) , e0324114
Community management: An effective model to reduce medication discontinuation rate in patients with schizophrenia
Background: Medication discontinuation is highly prevalent among patients with schizophrenia and is associated with poor clinical outcomes. Although community-based management models have been implemented in China to support patients, recent evidence of their effectiveness in reducing medication discontinuation rates remains limited. Methods: In this cross-sectional study, we surveyed 1,531 patients with schizophrenia under community management in Chengdu, China, using a multi-stage sampling approach. Data on treatment discontinuation (defined as cessation of all antipsychotics for >15 days without medical advice), socio-demographics, clinical characteristics, and service utilization were collected via face-to-face interviews. Univariate and multivariable logistic regression analyses were used to identify the factors associated with medication discontinuation. Results: The overall rate of medication discontinuation was 4.1%. Multivariable analysis identified several independent risk factors for discontinuation: weak stable disease state (adjusted odds ratio [aOR] = 2.70, 95% confidence interval [CI]: 1.34–5.24), lack of insight (aOR for partial vs. no insight = 0.25, 95% CI: 0.08–0.80; aOR for full vs. no insight = 0.18, 95% CI: 0.05–0.65), presence of noticeable side effects (aOR = 1.98, 95% CI: 1.05–3.64), and absence of regular follow-up (aOR for intermittent vs. no follow-up = 0.38, 95% CI: 0.20–0.72; aOR for regular vs. no follow-up = 0.22, 95% CI: 0.10–0.44). Conclusion: Community management was associated with a low rate of medication discontinuation in patients with schizophrenia. Key modifiable factors, including disease stability, insight, medication side effects, and follow-up adherence should be prioritized in community-based interventions to further improve treatment continuity.
- 9 January 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (1) , e0324114
Open AccessCommunity management: An effective model to reduce medication discontinuation rate in patients with schizophrenia
Background: Medication discontinuation is highly prevalent among patients with schizophrenia and is associated with poor clinical outcomes. Although community-based management models have been implemented in China to support patients, recent evidence of their effectiveness in reducing medication discontinuation rates remains limited. Methods: In this cross-sectional study, we surveyed 1,531 patients with schizophrenia under community management in Chengdu, China, using a multi-stage sampling approach. Data on treatment discontinuation (defined as cessation of all antipsychotics for >15 days without medical advice), socio-demographics, clinical characteristics, and service utilization were collected via face-to-face interviews. Univariate and multivariable logistic regression analyses were used to identify the factors associated with medication discontinuation. Results: The overall rate of medication discontinuation was 4.1%. Multivariable analysis identified several independent risk factors for discontinuation: weak stable disease state (adjusted odds ratio [aOR] = 2.70, 95% confidence interval [CI]: 1.34–5.24), lack of insight (aOR for partial vs. no insight = 0.25, 95% CI: 0.08–0.80; aOR for full vs. no insight = 0.18, 95% CI: 0.05–0.65), presence of noticeable side effects (aOR = 1.98, 95% CI: 1.05–3.64), and absence of regular follow-up (aOR for intermittent vs. no follow-up = 0.38, 95% CI: 0.20–0.72; aOR for regular vs. no follow-up = 0.22, 95% CI: 0.10–0.44). Conclusion: Community management was associated with a low rate of medication discontinuation in patients with schizophrenia. Key modifiable factors, including disease stability, insight, medication side effects, and follow-up adherence should be prioritized in community-based interventions to further improve treatment continuity.
- 26 September 2025
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 191, 323-332
Altered frontoparietal EEG rhythms in mild cognitive impairment during high-recall movie-watching
- 26 September 2025
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 191, 323-332
Altered frontoparietal EEG rhythms in mild cognitive impairment during high-recall movie-watching
- Open Access
Community management: A model that effectively reduces rate of medication discontinuation in patients with schizophrenia
Introduction: Patients with schizophrenia often experience high rates of medication interruptions, which have a range of serious consequences. Previous studies have shown that community management may help to address this situation. Objective: To investigate treatment discontinuation in patients with schizophrenia under community management in China and analyze its associated factors. Methods: The patients were assessed using a self-report questionnaire. The survey content included the following: treatment discontinuation, age, sex, education, residence, marital status, monthly family income, payment method for medication, employment, course of current disease, state of disease, insight, knowledge about drugs, types of drugs received, adverse effects of treatment, accepted follow-up, and family support. Results: A total of 1531 patients with schizophrenia were included. Among them, 63 patients (4.1%) had discontinued medication at some point, while 1468 (95.9%) patients maintained treatment. The two groups showed statistically significant differences in payment methods for medication, state of disease, insight, knowledge about drugs, side effects of drugs, type of drugs received, and status of follow-up visits ( P P <0.05). Conclusion: Patients with schizophrenia under community management had a low rate of treatment discontinuation. The state of the disease, insight, side-effects of drugs, and status of follow-up visits are strongly related to medication interruption.
Open AccessCommunity management: A model that effectively reduces rate of medication discontinuation in patients with schizophrenia
Introduction: Patients with schizophrenia often experience high rates of medication interruptions, which have a range of serious consequences. Previous studies have shown that community management may help to address this situation. Objective: To investigate treatment discontinuation in patients with schizophrenia under community management in China and analyze its associated factors. Methods: The patients were assessed using a self-report questionnaire. The survey content included the following: treatment discontinuation, age, sex, education, residence, marital status, monthly family income, payment method for medication, employment, course of current disease, state of disease, insight, knowledge about drugs, types of drugs received, adverse effects of treatment, accepted follow-up, and family support. Results: A total of 1531 patients with schizophrenia were included. Among them, 63 patients (4.1%) had discontinued medication at some point, while 1468 (95.9%) patients maintained treatment. The two groups showed statistically significant differences in payment methods for medication, state of disease, insight, knowledge about drugs, side effects of drugs, type of drugs received, and status of follow-up visits ( P P <0.05). Conclusion: Patients with schizophrenia under community management had a low rate of treatment discontinuation. The state of the disease, insight, side-effects of drugs, and status of follow-up visits are strongly related to medication interruption.